563 Search Results Found For : "www.nubobeauty.com"



Social Change in the Wake of the U.S. Recession

(2009) Between 2007 and 2008, U.S. household income fell sharply as the unemployment rate increased.

View Details

Project: Supporting Population Evidence and Champions in Africa (SPEC)

Harnessing the Demographic Dividend in Ethiopia

Ethiopia, with a current population of about 100 million, has achieved gains in several major health indicators.

View Details

Spread of HIV Is Slowing in Cambodia

(2003) In only 20 years, HIV/AIDS has developed into the most devastating epidemic the world has faced. Forty million individuals worldwide live with HIV/AIDS and millions more individuals, families, children, and communities affected by HIV/AIDS face multiple challenges.1 Yet while many countries continue to experience increasing HIV prevalence rates, Cambodia appears to be making progress.

View Details

What Are the Challenges to Conducting Abortion-Related Research in the United States? 

Two years after the Dobbs decision, researchers are using innovative methods to answer questions about women’s reproductive health.

View Details

Project: Empowering Evidence-Driven Advocacy

Infographic. Contraceptive Implant

The etonorgestrel (ENG)-releasing subdermal implant is a small plastic rod that is four centimeters in length and contains 68 milligrams of the progestin ENG. The implant is a long-acting reversible contraceptive method that is effective for three years. It must be inserted and removed by a trained provider and does not contain estrogen.

View Details Array ( [ID] => 11384 [id] => 11384 [title] => PHL_Fact_Sheets_Implants [filename] => PHL_Fact_Sheets_Implants.pdf [filesize] => 574052 [url] => https://www.prb.org/wp-content/uploads/2021/01/PHL_Fact_Sheets_Implants.pdf [link] => https://www.prb.org/resources/combined-oral-contraceptive/phl_fact_sheets_implants-2/ [alt] => [author] => 15 [description] => The etonorgestrel (ENG)-releasing subdermal implant is a small plastic rod that is four centimeters in length and contains 68 milligrams of the progestin ENG. The implant is a long-acting reversible contraceptive method that is effective for three years. It must be inserted and removed by a trained provider and does not contain estrogen. [caption] => [name] => phl_fact_sheets_implants-2 [status] => inherit [uploaded_to] => 11375 [date] => 2021-01-09 05:09:01 [modified] => 2021-01-09 05:18:43 [menu_order] => 0 [mime_type] => application/pdf [type] => application [subtype] => pdf [icon] => https://www.prb.org/wp-includes/images/media/document.png ) Download (0.6 MB)